April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Vivek Subbiah: Our latest commentary on Pediatric AML Trials
Jan 29, 2025, 18:53

Vivek Subbiah: Our latest commentary on Pediatric AML Trials

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on LinkedIn about recent paper by Vivek Subbiah and Branko Cuglievan, titled “Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncology” published on Nature Reviews.

Vivek Subbiah: Our latest commentary on Pediatric AML Trials

“Hot of the press.
Pleased to share our latest commentary in Nature Reviews Clinical Oncology. ‘Transforming Pediatric AML Trials: From Failing One-Size-Fits-All Methods to Precision Oncology.’ Thrilled to collaborate with my amazing colleague and friend and the brilliant Dr. Branko Cuglievan.”